Background Cardiac resynchronisation therapy (CRT) can be necessary in patients with
chronic heart failure, who have already been provided with transvenous cardiac implantable …

Background Cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in
appropriately selected patients with heart failure and is strongly recommended for such …

Background: Multiple randomised clinical trials have proven that cardiac resynchronisation
therapy (CRT) reduces morbidity and mortality in appropriately selected patients with …

Cardiac resynchronisation therapy (CRT) is common treatment for congestive heart failure
(HF) with decreased LV function and wide QRS complex. Its foundations are set in the …

Objective Revision to cardiac resynchronisation therapy (CRT) in patients with existing
pacemakers with worsening heart failure (HF) can improve symptoms and cardiac function …

BACKGROUND: Based on a reduction in morbidity and mortality, cardiac resynchronisation
therapy (CRT) has evolved as a standard therapy for patients with advanced heart failure …

Purpose Cardiac resynchronization therapy (CRT) reduces symptoms and improves survival
in patients with advanced heart failure (New York Heart Association (NYHA) functional class …

Introduction Current guidelines recommend cardiac resynchronisation therapy (CRT) in
patients with severe symptomatic heart failure, depressed left ventricular (LV) systolic …

Objectives To evaluate the clinical response to cardiac resynchronisation therapy (CRT) in
patients with heart failure and a normal QRS duration (< 120 ms). Setting Single centre …

Over the past 20 plus years, cardiac resynchronization therapy with defibrillation (CRT-D) or
without defibrillation (CRT-P) has become a wellrecognized therapeutic modality for patients …